Both in Pharmaceuticals
Bausch Health Companies vs Organon &
Over the past year BHC returned +43.2% and OGN returned +117.9%; their daily moves had a correlation of 0.10.
BHC +43.2% OGN +117.9%Growth of $1, one year, split-adjusted
| Metric | BHC | OGN |
|---|---|---|
| Price | $8.45 | $13.82 |
| Market cap | $3.16B | $3.63B |
| Today | −5.16% | +0.04% |
| 1 month | +47.5% | +0.8% |
| 6 months | +49.6% | +4.0% |
| Year to date | +21.6% | +92.7% |
| 1 year | +43.2% | +117.9% |
| Revenue growth (YoY) | +9.7% | −2.3% |
| Gross margin | 75.0% | 54.4% |
| Net margin | 14.8% | 6.9% |
| P/E (TTM) | — | 17.4× |
| Price / sales | 0.3× | 0.6× |
| Net cash | -$18.15B | -$7.42B |
| Dividend yield | — | 0.58% |
| Volatility (60d) | 67.0% | 2.9% |
| Short % of float | 3.1% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).